Alebund Pharmaceuticals (Jiangsu) Ltd (9637)

Currency in HKD
19.18
+0.71(+3.84%)
Closed·
9637 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
17.9819.55
52 wk Range
14.3646.82
Key Statistics
Bid/Ask
18.90 / 19.18
Prev. Close
19.18
Open
18
Day's Range
17.98-19.55
52 wk Range
14.36-46.82
Volume
667.42K
Average Volume (3m)
822.45K
1-Year Change
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
9637 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
48.69
Upside
+153.87%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 48.69
(+153.87% Upside)

Earnings

Latest Release
Aug 26, 2026
EPS / Forecast
-0.57 / --
Revenue / Forecast
104.16M / --
EPS Revisions
Last 90 days

9637 Income Statement

Compare 9637 to Peers and Sector

Metrics to compare
9637
Peers
Sector
Relationship
P/E Ratio
−7.9x8.2x−0.2x
PEG Ratio
-0.000.00
Price/Book
3.9x2.6x2.6x
Price / LTM Sales
45.3x5.4x2.8x
Upside (Analyst Target)
153.6%50.2%62.1%
Fair Value Upside
Unlock5.9%9.5%Unlock

Alebund Pharmaceuticals (Jiangsu) Limited operates as a biopharmaceutical company that develops therapies for kidney diseases and their complications in China and Hong Kong. Its products include AP301, a phosphate binder; AP306, a sodium-dependent phosphate transport protein inhibitor; one early-clinical-stage product candidate AP303; and four preclinical product candidates, including AP308, AP304, AP305, and AP307. Alebund Pharmaceuticals (Jiangsu) Limited was founded in 2018 and is headquartered in Yangzhou, China.

Employees
169
Market
Hong Kong

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
4.65M1.37%80.98M
Other Institutional Investors
399.89M98.63%6.96B
Public Companies & Retail Investors
0.000.00%0.00
Total
404.54M100.00%7.04B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Guangxi Tencent Venture Capital Investment Co., Ltd.9.11%30,965,311538,796
Yangzhou Venture Capital Co., Ltd.8.01%27,224,472473,706

People Also Watch

25.92
2577
-7.03%
454.80
6990
-1.52%
34.52
1651
-6.55%
20.66
2367
-2.46%

FAQ

What Is the Alebund Pharms (9637) Stock Price Today?

The Alebund Pharms stock price today is 19.18 HKD.

What Stock Exchange Does Alebund Pharms Trade On?

Alebund Pharms is listed and trades on the Hong Kong Stock Exchange.

What Is the Stock Symbol for Alebund Pharms?

The stock symbol for Alebund Pharms is "9637."

What Is the Alebund Pharms Market Cap?

As of today, Alebund Pharms market cap is 6.52B HKD.

What Is Alebund Pharms's Earnings Per Share (TTM)?

The Alebund Pharms EPS (TTM) is -2.99.

From a Technical Analysis Perspective, Is 9637 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Alebund Pharms Stock Split?

Alebund Pharms has split 0 times.

How Many Employees Does Alebund Pharms Have?

Alebund Pharms has 169 employees.

What is the current trading status of Alebund Pharms (9637)?

As of Nov 06, 2026, Alebund Pharms (9637) is trading at a price of 19.18 HKD, with a previous close of 19.18 HKD. The stock has fluctuated within a day range of 17.98 HKD to 19.55 HKD, while its 52-week range spans from 14.36 HKD to 46.82 HKD.

What Is Alebund Pharms (9637) Price Target According to Analysts?

The average 12-month price target for Alebund Pharms is 48.69 HKD, with a high estimate of 52.25851939 HKD and a low estimate of 41.62514689 HKD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +153.87% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.